HR 5316 · 119th Congress · Health
Drug Shortage Compounding Patient Access Act of 2025
Bill Progress
✓
Introduced2
Committee3
House Vote4
Senate5
EnactedLatest: Referred to the House Committee on Energy and Commerce.(2025-09-11)
Plain Language Summary
[AI summary unavailable — showing source text]
[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 5316 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. R. 5316 To amend the Federal Food, Drug, and Cosmetic Act to ensure patients have access to certain shortage and urgent-use compounded medications, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES September 11, 2025 Mrs. Harshbarger (for herself and Mr. Carter of Georgia) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To amend the Federal Food, Drug, and Cosmetic Act to ensure patients have access to certain shortage and urgent-use compounded medications, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Drug Shortage Compounding Patient Access Act of 2025''. SEC. 2. PHARMACY COMPOUNDING. (a) Compounding for Urgent Administration to Patients.--Section 503A(a) of the Federal Food, Drug, an…
Summarized by Claude AI · Non-partisan · For informational purposes only
Cosponsors (3)
3 Republicans